Market Cap

Akero Therapeutics, Inc. Market Capitalization:

$4.50 Billion

USD as of Dec. 1, 2025

business Akero Therapeutics, Inc. Company Profile

Akero Therapeutics, Inc. Main Stock Listing

NASDAQ: AKRO

Market Capitalization History of Akero Therapeutics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Akero Therapeutics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2025 $1.83 B 43.44%
Jan. 1, 2024 $1.27 B -45.81%
Jan. 1, 2023 $2.35 B 174.32%
Jan. 1, 2022 $856.3 M -40.45%
Jan. 1, 2021 $1.44 B 19.16%
Jan. 1, 2020 $1.21 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Akero Therapeutics, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Akero Therapeutics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: AKRO

Stock: FSX: 0K4

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.